189 related articles for article (PubMed ID: 23845572)
1. New approaches in the management of male breast cancer.
Patten DK; Sharifi LK; Fazel M
Clin Breast Cancer; 2013 Oct; 13(5):309-14. PubMed ID: 23845572
[TBL] [Abstract][Full Text] [Related]
2. [Male breast cancer: a review].
Comet B; Cutuli B; Penault-Llorca F; Bonneterre J; Belkacémi Y
Bull Cancer; 2009 Feb; 96(2):181-9. PubMed ID: 19258225
[TBL] [Abstract][Full Text] [Related]
3. Male breast cancer in the veterans affairs population: a comparative analysis.
Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
[TBL] [Abstract][Full Text] [Related]
4. Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis.
Fields EC; DeWitt P; Fisher CM; Rabinovitch R
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):747-52. PubMed ID: 24138917
[TBL] [Abstract][Full Text] [Related]
5. Similarities and differences in the characteristics and primary treatment of breast cancer in men and women - a population based study (Sweden).
Nilsson C; Holmqvist M; Bergkvist L; Hedenfalk I; Lambe M; Fjällskog ML
Acta Oncol; 2011 Oct; 50(7):1083-8. PubMed ID: 21830994
[TBL] [Abstract][Full Text] [Related]
6. First-line chemotherapy for metastatic breast cancer.
Telli ML; Carlson RW
Clin Breast Cancer; 2009 Jun; 9 Suppl 2():S66-72. PubMed ID: 19596645
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer in men.
Buzdar AU
Oncology (Williston Park); 2003 Oct; 17(10):1361-4; discussion 1364, 1369-72. PubMed ID: 14606362
[TBL] [Abstract][Full Text] [Related]
8. Male breast cancer: a survey at the Helsinki University Central Hospital during 1981-2006.
Liukkonen S; Saarto T; Mäenpää H; Sjöström-Mattson J
Acta Oncol; 2010 Apr; 49(3):322-7. PubMed ID: 20397767
[TBL] [Abstract][Full Text] [Related]
9. Hormonal therapy for male breast cancer: A different approach for a different disease.
Nahleh ZA
Cancer Treat Rev; 2006 Apr; 32(2):101-5. PubMed ID: 16472925
[TBL] [Abstract][Full Text] [Related]
10. Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade?
Banz-Jansen C; Heinrichs A; Hedderich M; Waldmann A; Wedel B; Mebes I; Diedrich K; Rody A; Fischer D
Arch Gynecol Obstet; 2013 Aug; 288(2):379-83. PubMed ID: 23407999
[TBL] [Abstract][Full Text] [Related]
11. [Clinical research advancement on male breast cancer].
Xue Y; Guo XT; Liu WC
Ai Zheng; 2007 Oct; 26(10):1148-52. PubMed ID: 17927890
[TBL] [Abstract][Full Text] [Related]
12. Beyond cytotoxic chemotherapy for the first-line treatment of HER2-negative, hormone-insensitive metastatic breast cancer: current status and future opportunities.
Conlin AK; Seidman AD
Clin Breast Cancer; 2008 Jun; 8(3):215-23. PubMed ID: 18650151
[TBL] [Abstract][Full Text] [Related]
13. [Three men with breast cancer].
Bergs EA; Tanis PJ; Steller EP
Ned Tijdschr Geneeskd; 2005 Mar; 149(10):534-7. PubMed ID: 15782690
[TBL] [Abstract][Full Text] [Related]
14. Achievements in systemic therapies in the pregenomic era in metastatic breast cancer.
Colozza M; de Azambuja E; Personeni N; Lebrun F; Piccart MJ; Cardoso F
Oncologist; 2007 Mar; 12(3):253-70. PubMed ID: 17405890
[TBL] [Abstract][Full Text] [Related]
15. An updated review of epidemiology, risk factors, and management of male breast cancer.
Khan NAJ; Tirona M
Med Oncol; 2021 Mar; 38(4):39. PubMed ID: 33721121
[TBL] [Abstract][Full Text] [Related]
16. Male breast cancer.
Gómez-Raposo C; Zambrana Tévar F; Sereno Moyano M; López Gómez M; Casado E
Cancer Treat Rev; 2010 Oct; 36(6):451-7. PubMed ID: 20193984
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of patients with metastatic breast cancer: results of a retrospective, single-center analysis from 2000 to 2005.
Geiger S; Cnossen JA; Horster S; DiGioia D; Heinemann V; Stemmler HJ
Anticancer Drugs; 2011 Oct; 22(9):933-9. PubMed ID: 21666437
[TBL] [Abstract][Full Text] [Related]
18. Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases.
Cutuli B; Le-Nir CC; Serin D; Kirova Y; Gaci Z; Lemanski C; De Lafontan B; Zoubir M; Maingon P; Mignotte H; de Lara CT; Edeline J; Penault-Llorca F; Romestaing P; Delva C; Comet B; Belkacemi Y
Crit Rev Oncol Hematol; 2010 Mar; 73(3):246-54. PubMed ID: 19442535
[TBL] [Abstract][Full Text] [Related]
19. A case of HER2-positive male breast cancer with lung metastases showing a good response to trastuzumab and paclitaxel treatment.
Hayashi H; Kimura M; Yoshimoto N; Tsuzuki M; Tsunoda N; Fujita T; Yamashita T; Iwata H
Breast Cancer; 2009; 16(2):136-40. PubMed ID: 18548321
[TBL] [Abstract][Full Text] [Related]
20. A review of the treatment of endocrine responsive metastatic breast cancer in postmenopausal women.
Cardoso F; Bischoff J; Brain E; Zotano ÁG; Lück HJ; Tjan-Heijnen VC; Tanner M; Aapro M
Cancer Treat Rev; 2013 Aug; 39(5):457-65. PubMed ID: 22840697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
